Atlas Trials

A Study of Anti-PD-1 Combinations of D-CIK Immunotherapy and Axitinib in Advanced Ranal Carcinoma

Clinical trial NCT03736330 · UNKNOWN

Trial details

NCT number
NCT03736330
Sponsor
Sun Yat-sen University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Renal Cancer Metastatic
Start date
2018-09-08
Primary completion
2020-10-08
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.